3.29 USD
↘ 0.15 (4.48%)LIVE (AS OF 10:29 AM EDT)
Insight Molecular Diagnostics Inc. Common Stock
IMDXNASDAQ • USD
Market: OPEN
Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $3.29. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (231.7%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 2, 2026.
Open?$3.44
High?$3.49
Low?$3.21
Prev. Close?$3.44
Volume?77.5K
Avg. Volume?241.1K
VWAP?$3.28
Rel. Volume?0.32x
Bid / Ask
Bid?$2.78 × 100
Ask?$3.35 × 100
Spread?$0.57
Midpoint?$3.07
Valuation & Ratios
Market Cap?112.6M
Shares Out?32.7M
Float?25.5M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?-5.29
EPS?-$1.51
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Employees
58
Market Cap
112.6M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?64
Piotroski F-Score?0/9Weak
Altman Z-Score?-24.29Distress
Confidence?46%Low
Short InterestModerate
Short % of Float?3.90%Low
Short Interest?992.5K
Days to Cover?4.8
Free Float25.5M
Avg Daily Volume208.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.00Strong
Quick Ratio?1.98Adequate
Cash Ratio?1.73Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-5.29CHEAP▾
S&P97
P/S?67.41HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.4CHEAP▾
S&P97
EV/Sales?56.78HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?231.7%STRONG▾
Peers50
S&P97
ROA?-167.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-30875000
Enterprise Value?$94.8M
Fundamentals ratios updated end of day